Found: 4
Select item for more details and to access through your institution.
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan.
- Published in:
- 2019
- By:
- Publication type:
- journal article
First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Correction: Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201956
- By:
- Publication type:
- Article